The carbocyclic ring undergoes a conformational change to
a boat form IV so that the three axially orienting hydroxyl
groups adopt more stable equatorial orientation. This might
also make the heterocyclic chair to undergo a conformational
change to its boat form V so that the 2-OH can have stabilizing
interaction with dioxenium. The boat–boat conformer V can, in
principle, react to form the 1,2,3-orthoester VI. The unstable and
strained orthoester VI can undergo acid catalyzed orthoester
cleavage to the 1,2- or 2,3-dioxolenium VII which will easily
rearrange to its more stable chair form IX. Attack of the
dioxolenium IX by water adsorbed on H2SO4–silica leads to
the formation of the unstable orthoacid X, which is known22,23
to decompose into a hydroxyl ester with an axially orienting ester
and an equatorial hydroxyl group. This mechanism explains the
unreactivity of sulfite 12 as its locked conformation would not
allow the conformational change from III to IV which in turn
prevents the formation of the crucial dioxolenium intermediate
IX. While, the orthoester pathway is definitely in action for
the observed selectivity, concurrent action of other pathways
cannot be ruled out. For instance, the transformation of the
pre-synthesized orthoester 4 to the 2-O-ester 3a took longer time
when the reaction was done in dry DMF with 3 equivalents of
methanol, the exact mimic of the direct 2-O-acylation reaction
medium (in the direct 2-O-acylation reaction, for each molecule
of the intermediate orthoester produced, three molecules of
methanol will be released to the solvent). So another relatively
faster pathway also may be in action in the direct 2-O-acylation
reaction. This is not inconceivable as the kinetic and less stable
(more reactive) 1,2-orthoester of inositol VIII can also give
the dioxolenium ion IX and thus the orthoacid X under acidic
conditions.
general and high-yielding methodology for the regioselective
2-O-acylation of myo-inositol. This methodology is very attrac-
tive in the light of natural occurrence of many 2-O-acyl-myo-
inositols having interesting biological activities. Our method not
only provides easy access to these natural products and their
analogs but also the shortest route for the synthesis of the
anticancer agent myo-inositol 1,3,4,5,6-pentakisphosphate.
KMS thank DST and CSIR for a Ramanujan Fellowship
and financial support.
Notes and references
1 C. A. Lewis and S. J. Miller, Angew. Chem., Int. Ed., 2006, 45,
5616–5619.
2 T. Kawabata, W. Muramatsu, T. Nishio, T. Shibata and
H. Schedel, J. Am. Chem. Soc., 2007, 129, 12890–12895.
3 K. S. Griswold and S. J. Miller, Tetrahedron, 2003, 59, 8869–8875.
4 Y. Demizu, Y. Kubo, H. Miyoshi, T. Maki, Y. Matsumura,
N. Moriyama and O. Onomura, Org. Lett., 2008, 10, 5075–5077.
5 E. Kattnig and M. Albert, Org. Lett., 2004, 6, 945–948.
6 T. Kurahashi, T. Mizutani and J. Yoshida, Tetrahedron, 2002, 58,
8669–8677.
7 C.-C. Wang, J.-C. Lee, S.-Y. Luo, S. S. Kulkarni, Y.-W. Huang,
C.-C. Lee, K.-L. Chang and S.-C. Hung, Nature, 2007, 446,
896–899.
8 C.-C. Wang, J.-C. Lee, S.-Y. Luo, H.-F. Fan, C.-L. Pai,
W.-C. Yang, L.-D. Lu and S.-C. Hung, Angew. Chem., Int. Ed.,
2002, 41, 2360–2362.
9 A. Francais, D. Urban and J.-M. Beau, Angew. Chem., Int. Ed.,
2007, 46, 8662–8665.
10 M. J. Berridge, M. D. Bootman and H. L. Roderick, Nat. Rev.
Mol. Cell Biol., 2003, 4, 517–529.
11 R. F. Irvine and M. J. Schell, Nat. Rev. Mol. Cell Biol., 2001, 2,
327–338.
12 K. S. Bruzik, Phosphoinositides: Chemistry, Biochemistry and
Biomedical Applications, ACS Symp. Ser., 1999, 718, 1–312.
13 C. L. Carpenter and L. C. Cantley, Biochemistry, 1990, 29,
11147–11156.
Though 2-OH is the least reactive in chemical reactions
among all the hydroxyl groups of inositol, O2 acylation is
common among inositol based natural products24,25 and is
important for the biological functions of various natural
products. For instance, GPI anchors are acylated at O2 of
inositol and this ester motif has a role in the stability of the
anchor toward Phospholipase C (PLC) action.26 Lanceolitols,
a series of 2-O-acyl-myo-inositol glycosides with diversity in
the fatty acyl chain isolated from Solanum lanceolatum, are
potent COX-2 inhibitors and hence are anti-inflammatory.27
These facts highlight the importance of the selective 2-O-
acylation reported here. Trifluoroacetic acid mediated28 and
Pd(OH)2 mediated29 cleavages of the benzoate 4 to the pentol
3a have been reported. Potter et al. exploited this for the
efficient and elegant synthesis of the anticancer agent, myo-
inositol 1,3,4,5,6-pentakisphosphate [Ins(1,3,4,5,6)P5] in three
straightforward steps.28 The fact that our method affords the
precursor 3a in a single step from inositol in a highly selective
manner provides an easy access to this anticancer agent.
In conclusion, we have reported a highly regioselective
acylation of an otherwise unreactive hydroxyl group of myo-
inositol. Ours is the first report of the regioselective mono-
functionalization among six equivalent hydroxyl groups. The
very cheap and easy-to-make H2SO4–silica catalyzed tandem
transorthoesterification–hydrolysis sequence offers a simple,
14 R. H. Michell, V. L. Heath, M. A. Lemmon and S. K. Dove,
Trends Biochem. Sci., 2006, 31, 52–63.
15 B. V. L. Potter and D. Lampe, Angew. Chem., Int. Ed. Engl., 1995,
34, 1933–1972.
16 S. J. Conway and G. J. Miller, Nat. Prod. Rep., 2007, 24,
687–707.
17 H. W. Lee and Y. Kishi, J. Org. Chem., 1985, 50, 4402–4404.
18 M. S. Shashidhar, ARKIVOC, 2002, (7), 63–75.
19 V. K. Rajput and B. Mukhopadhyay, Tetrahedron Lett., 2006, 47,
5939–5941.
20 K. M. Sureshan, M. S. Shashidhar, T. Praveen and T. Das, Chem.
Rev., 2003, 103, 4477–4503.
21 S.-K. Chung, Y.-U. Kwon, J.-H. Shin, Y.-T. Chang, C. Lee,
B.-G. Shin, K.-C. Kim and M.-J. Kim, J. Org. Chem., 2002, 67,
5626–5637.
22 J. F. King and A. D. Allbutt, Can. J. Chem., 1970, 48, 1754–1769.
23 R. U. Lemieux and H. Driguez, J. Am. Chem. Soc., 1975, 97,
4069–4075.
24 O. Spring, R. Zipper, S. Reeb, B. Vogler and F. B. Da Costa,
Phytochemistry, 2001, 57, 267–272.
25 F. B. Da Costa, K. Schorr, N. S. Arakawa, E. E. Schilling and
O. Spring, J. Braz. Chem. Soc., 2001, 12, 403–407.
26 A. Treumann, N. Zitzmann, A. Hulsmeier, A. R. Prescott,
A. Almond, J. Sheehan and M. A. J. Ferguson, J. Mol. Biol.,
1997, 269, 529–547.
27 Y. Herrera-Salgado, M. L. Garduno-Ramirez, L. Vazquez,
M. Y. Rios and L. Alvarez, J. Nat. Prod., 2005, 68, 1031–1036.
28 H. Y. Godage, A. M. Riley, T. J. Woodman and B. V. L. Potter,
Chem. Commun., 2006, 2989–2991.
29 C. Murali, M. S. Shashidhar and C. S. Gopinath, Tetrahedron,
2007, 63, 4149–4155.
c
2450 Chem. Commun., 2012, 48, 2448–2450
This journal is The Royal Society of Chemistry 2012